SCI & TECH● LOWOct 5 · Oct 5, 2026, 2:53 PM
Vaxcyte jumps on phase 3 data for pneumonia vaccine VAX-31
Seeking Alpha Tech · global
Vaxcyte stock has risen following positive phase 3 data for its pneumonia vaccine, VAX-31. This development indicates potential progress in a new medical treatment.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Sci & Tech
SCI & TECH33m agoI tried Apple’s new smart home hub – the brand faithful will love itThe TelegraphSCI & TECH38m agoThe Future of AI CryptanalysisSchneierSCI & TECH46m agoWhen AI agents become economic actors, what happens to money and the financial system?Atlantic CouncilSCI & TECH1h agoEntire Swedish reality show season lost weeks before premiere amid disputed AI claimsEuroNews [en]